The Effect of Augmented Reality Based Training on Preeclampsia Case
Launched by INONU UNIVERSITY · Dec 8, 2024
Trial Information
Current as of July 12, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how using augmented reality (AR) training can help nursing students learn to recognize and manage preeclampsia, a serious condition that can affect pregnant women and their babies. The goal is to see if AR technology can improve their skills in diagnosing this condition and planning the right care.
To participate, women aged 18 to 35 who are currently studying Women's Health and Diseases Nursing and are willing to volunteer for the study can apply. Participants must be healthy enough to complete the research forms and should attend classes, including a special lecture on preeclampsia. The trial is not yet recruiting participants, so interested individuals will need to wait for it to start. This study could help enhance nursing education and ultimately lead to better care for mothers and babies facing preeclampsia.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Continuing the course of Women's Health and Diseases Nursing,
- • Volunteering to participate in the research,
- • No physical or psychological health problems preventing the completion of the research forms.
- Exclusion Criteria:
- • - Not watching the whole case given with virtual glasses,
- • Failure to attend class during the week of the preeclampsia lecture in the course syllabus.
About Inonu University
Inonu University is a prominent academic institution located in Turkey, dedicated to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive resources and expertise to facilitate innovative research initiatives aimed at improving patient care and advancing scientific knowledge. With a strong commitment to ethical standards and regulatory compliance, Inonu University collaborates with various stakeholders, including healthcare professionals and industry partners, to conduct rigorous clinical trials that contribute to the development of new therapies and treatment modalities. Through its research endeavors, the university strives to enhance healthcare outcomes and foster a culture of inquiry within the medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Malatya, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported